Pulmonary Rehabilitation Before Lung Cancer Resection

Description

This is a study funded by the National Institute of Health. The rationale for the need of this research is the lack of any well proven risk-reducing intervention that may decrease the morbidity of lung cancer resection in patients with COPD or that may improve their quality of life trajectory, a meaningful outcome in the overall disease progression. The proposed intervention is unique as it combines exercise and behavioral interventions that were pilot tested in a randomized single-blinded controlled design in the proposed population and proved feasible and potentially effective. The aim is to test the effect of the proposed rehabilitation on length of stay, pulmonary complications and quality of life trajectory.

Study Start Date

March, 15 2017

Estimated Completion Date

December 2020

Interventions

  • Procedure: rehabilitation
  • Other: education
  • Device: pedometer
  • Procedure: surgery

Study ID

Alliance for Clinical Trials in Oncology -- A221502

Status

Recruiting

Trial ID

NCT02887521

Study Type

Interventional

Trial Phase

Phase 3

Enrollment Quota

194

Sponsor

Alliance for Clinical Trials in Oncology

1. Patient is scheduled to undergo NSCLC resection: video assisted thoracoscopy (VATS) or open thoracotomy for: limited resection, lobectomy, or pneumonectomy. Surgery must not be scheduled to take place < 3 weeks after registration. 2. Patient has a doctor diagnosis of COPD. 3. Patient is a current or ex-smoker with a smoking history of ? 10 pack years. (Calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked. For example, 1 pack-year is equal to smoking 20 cigarettes (1 pack) per day for 1 year, or 40 cigarettes per day for half a year, and so on). 4. Age ? 18 yrs

Gender

All

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (15)

Study Location Distance Name Phone Email
Alliance for Clinical Trials in Oncology - Boston, Massachusetts 2.6 miles Roberto P Benzo 507-284-0561 benzo.roberto@mayo.edu
Alliance for Clinical Trials in Oncology - Boston, Massachusetts 2.6 miles Roberto P Benzo 507-284-0561 benzo.roberto@mayo.edu
Alliance for Clinical Trials in Oncology - Boston, Massachusetts 2.6 miles Roberto P Benzo 507-284-0561 benzo.roberto@mayo.edu
Alliance for Clinical Trials in Oncology - Boston, Massachusetts 2.6 miles Roberto P Benzo 507-284-0561 benzo.roberto@mayo.edu
Alliance for Clinical Trials in Oncology - Boston, Massachusetts 2.6 miles Roberto P Benzo 507-284-0561 benzo.roberto@mayo.edu
Saint Vincent Hospital Cancer Center Green Bay - Green Bay, Wisconsin 861.8 miles Anthony J Jaslowski 920-433-8889 Christy.Gilchrist@hshs.org
Saint Vincent Hospital Cancer Center Green Bay - Green Bay, Wisconsin 861.8 miles Anthony J Jaslowski 920-433-8889 Christy.Gilchrist@hshs.org
Saint Vincent Hospital Cancer Center Green Bay - Green Bay, Wisconsin 861.8 miles Anthony J Jaslowski 920-433-8889 Christy.Gilchrist@hshs.org
Saint Vincent Hospital Cancer Center Green Bay - Green Bay, Wisconsin 861.8 miles Anthony J Jaslowski 920-433-8889 Christy.Gilchrist@hshs.org
Saint Vincent Hospital Cancer Center Green Bay - Green Bay, Wisconsin 861.8 miles Anthony J Jaslowski 920-433-8889 Christy.Gilchrist@hshs.org
Mayo Clinic - Rochester, Minnesota 1,083.1 miles Roberto P Benzo 855-776-0015 None
Mayo Clinic - Rochester, Minnesota 1,083.1 miles Roberto P Benzo 855-776-0015 None
Mayo Clinic - Rochester, Minnesota 1,083.1 miles Roberto P Benzo 855-776-0015 None
Mayo Clinic - Rochester, Minnesota 1,083.1 miles Roberto P Benzo 855-776-0015 None
Mayo Clinic - Rochester, Minnesota 1,083.1 miles Roberto P Benzo 855-776-0015 None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.